Sichenzia Ross Ference Kesner LLP

Author Archives: Sichenzia Ross Ference Kesner LLP

Partner Benjamin Tan Joins China Internet Nationwide Financial Services, Inc. in Ringing the Closing Bell at Nasdaq MarketSite

Press Release – New York, NY – August 16, 2017 – Sichenzia Ross Ference Kesner LLP partner,  Benjamin Tan joined China Internet Nationwide Financial Services, Inc. (NASDAQ: CIFS) , a provider of financial advisory services to the underserved small-to-medium sized enterprises in China, in ringing the closing bell at Nasdaq MarketSite in Times Square on August 15, 2017. CIFS recently closed on an initial public offering of 2,023,146 ordinary shares for a total of $20,231,460 at $10.00 per share on July 31, 2017  and its shares currently trade on the NASDAQ Global Market.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $11.8 PIPE financing of Aytu Bioscience, Inc.

aytu bioscience

Press Release – New York, NY – November 2, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co.  as lead placement agent and Fordham Financial Management, Inc. co-placement agent  in a private placement offering of equity securities of Aytu BioScience, Inc.  (OTC Market “AYTU”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $8.6 Million Registered Direct Offering

vuzix view the future logo

Press Release – New York, NY – August 14, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 1.5 million registered shares of its common stock at a price of $5.75 per share  for gross proceeds to Vuzix of $8,625,000.Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, and Counsel Jeff Cahlon.

Sichenzia Ross Ference Kesner LLP Represents JetSmarter Inc. in Institutional Investment from Clearlake Capital Group and Leucadia National Corporation

Press Release — August 10, 2017 — New York, NY — Sichenzia Ross Ference Kesner LLP represented JetSmarter Inc., an innovative technology company and market leader in the premium private-flight-sharing economy, in an institutional capital raise.  The investment was anchored by lead sponsor, Clearlake Capital Group, L.P. and included participation from Leucadia National Corporation and existing investors.  Jefferies LLC acted as the exclusive placement agent to JetSmarter Inc. in connection with the financing.

continue reading >>

Tax Court:  Foreign investors not taxable on sales/liquidations, of U.S. partnership interests

The U.S. Tax Court has ruled that a foreign investor in a U.S. (non-real estate) partnership is not taxable on his gain from the liquidation of the partnership.  The Court ruled that the transaction was essentially the same as a sale of stock in a U.S. corporation (which is also not taxed when the stockholder is not a U.S. person).  Grecian Magnesite Mining, Industrial & Shipping Co., SA v. Com’r,  149 T.C. No. 3, July 13, 2017. The decision has no impact on  liquidations of interests in real estate partnerships, which are always taxable under FIRPTA.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents CloudCommerce, Inc., in Acquisition of Parscale Creative, Inc.

Press Release – New York, NY – August 2, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented CloudCommerce, Inc., a global provider of cloud-driven e-commerce and mobile commerce solutions, in its acquisition of Parscale Creative, Inc., a company engaged in the digital marketing business, through a forward triangular merger with Parscale Digital, Inc., a newly formed wholly owned subsidiary of CloudCommerce, Inc.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Medovex Corp. in Registered Direct Offering

medovex corporation

Press Release — New York, NY — August 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented Medovex Corp. (NASDAQ:MDVX), a medical products manufacturer, in a registered direct offering of units consisting of 2,956,046 shares of common stock and 1,478,023 warrants to purchase common stock at a price of $0.91 per unit resulting in gross proceeds of $2,680,000.

The Sichenzia Ross Ference Kesner LLP team was led by partners Harvey Kesner and Arthur Marcus. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents China Internet Nationwide Financial Services Inc. on $20 Million Public Offering

china internet nationwide financial services

Press Release – New York, NY – July 31, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS), a provider of financial advisory services to the underserved small-to-medium sized enterprises in China, in an initial public offering of 2,023,146 ordinary shares for a total of $20,231,460 at $10.00 per share. The shares are expected to begin trading on the NASDAQ Global Market on August 8, 2017 under the symbol “CIFS.”

continue reading >>

Sichenzia Ross Ference Kesner’s Jodi Zimmerman Conducts Q&A on “What You Should Know About Creating A Last Will & Testament”

Press Release – New York, NY – July 26, 2017 – Jodi B. Zimmerman, Esq. of Sichenzia Ross Ference Kesner LLP participated in a Q&A blog post hosted by eSignatureGuarantee Group, to share “What You Should Know About Creating A Last Will & Testament.” The Q&A outlines the reasons for planning ahead, what to be aware of, and most importantly — the impact on your family and community.

Read the entire post here.

Partner Harvey Kesner Rings Nasdaq Opening Bell with Laidlaw & Company (UK) Ltd. and Therapix Biosciences Ltd.

Press Release – New York, NY – June 28, 2017 – Sichenzia Ross Ference Kesner LLP partner Harvey Kesner joined representatives of Laidlaw & Company (UK) Ltd. and Therapix Biosciences Ltd., at the Nasdaq MarketSite in Times Square to ring the June 28, 2017 opening bell.

Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs. The company’s American Depository Shares (ADSs) have traded on The Nasdaq Capital Market under the symbol “TRPX” since March 22, 2017.

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a $7.4 Million Public Offering of Medical Transcript Billing, Corp.

mtbc - medical transcription billing corp. logo

Press Release – New York, NY – June 23, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcription Billing, Corp. (MTBC.NASDAQ). MTBC is a principal provider of proprietary, cloud-based electronic health records, practice management, and mHealth solutions.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Immuron Limited on $6.1M IPO and NASDAQ listing

immuron

Press Release — New York, NY — June 14, 2017 — Sichenzia Ross Ference Kesner LLP (“SRFK”) announced today the Firm has represented Immuron Limited (NASDAQ: IMRN) (ASX : IMC), a clinical-stage biopharmaceutical company focused on NASH and OTC products, on the company’s U.S. underwritten public offering of American Depository Shares (ADSs) and warrants to purchase the company’s ADSs at a combined offering price of $10.00.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, and Fordham Financial Management in $6.6 Registered Direct offering of Ampio Pharmaceuticals, Inc.

ampio pharmaceuticals

Press Release – New York, NY – June 8, 2017 – Nationally recognized securities and corporate law firm, Sichenzia Ross Ference Kesner LLP, announced today that it has represented Joseph Gunnar & Co. as Lead Placement agent and Fordham Financial Management as Co-Placement Agent  in a $6.6 million Registered Direct public offering of equity securities of Ampio Pharmaceuticals, Inc.(“NYSE MKT.AMPE”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Announces the Addition of an Established Commercial Real Estate Practice Group and Trust & Estates Practice Area

Press Release – New York, NY – June 7, 2017 – Sichenzia Ross Ference Kesner LLP (SRFK), a leading corporate securities and full service law firm, is pleased to announce the addition of a Commercial Real Estate group and Trusts & Estates practice to its growing number of practice areas.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents MabVax Therapeutics Holdings, Inc. on $4.1 Million Public Offering

mabvax therapeutics

Press Release – New York, NY – June 5, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX), a clinical-stage oncology drug development company, in a public offering of common stock and Series G Preferred Stock for a total of $4.1 million. continue reading >>

Sichenzia Ross Ference Kesner LLP Advises Dataram Corporation on the Acquisition of U.S. Gold Corp.

Press Release – New York, NY – May 31, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced that it has represented Dataram Corporation (NASDAQ: DRAM), a manufacturer of memory products and provider of performance solutions, in its acquisition of U.S. Gold Corp., an exploration stage mining company. The Sichenzia Ross Ference Kesner LLP team was led by Partners Harvey Kesner and Tara Guarneri-Ferrara and associate Nazia Khan.

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar & Co. and Brookline Capital Markets in a $13.25 PIPE for MRI Interventions, Inc.

mri interventions

Press Release – New York, NY – May 26, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC, as lead Placement Agent and Brookline Capital Markets, a division of CIM Securities, LLC, as co-Placement Agent in a $13.25 Million PIPE transaction for MRI Interventions, Inc. (OTCQB: MRIC) a medical device company that is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain.

continue reading >>

Sichenzia Ross Ference Kesner LLP Attorneys Marc Ross and Mendy Piekarski Achieve Complete Dismissal of Shareholder Derivative Lawsuit

Press Release – New York, NY – May 24, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP recently achieved a complete dismissal of a shareholder derivative lawsuit. The shareholder plaintiff filed the derivative lawsuit in Arizona state court, asserting claims against former and current directors and officers of a company that had issued a restatement of its financial statements.

continue reading >>

Sichenzia Ross Ference Kesner Associate Cass Sanford Quoted in Business Insider Article on Topics Surrounding Reg A+

Press Release – New York, NY – May 12, 2017 – Sichenzia Ross Ference Kesner LLP associate Cass Sanford was recently quoted in a Business Insider article, sharing her insight surrounding Regulation A+ investment offerings, and why the JOBS Act mechanism for raising capital should still be considered in its infancy.

continue reading >>

Sichenzia Ross Ference Kesner LLP Advises PolarityTE, Inc. on Acquisition of Intellectual Property Related to Regenerative Medicine

Press Release – New York, NY – May 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced that it has represented PolarityTE, Inc. (NASDAQ: COOL), a company which has developed and distributed software through online platforms and is also engaged in regenerative medicine, in its acquisition of intellectual property related to a novel regenerative medicine and tissue engineering platform developed by Dr. Denver Lough, the Company’s current Chief Executive Officer. The Sichenzia Ross Ference Kesner LLP team was led by Partners Harvey Kesner and Tara Guarneri-Ferrara and associate Nazia Khan. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. in $5.2 Million Public Offering

onconova logo

Press Release – New York, NY – May 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as sole book-running manager in the underwritten public offering of equity securities of Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). In connection with the offering, Onconova received approximately $5.2 million in gross proceeds from common stock sold at a price to the public of $2.10 per share.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Cooltech Holding Corp. in a Private Placement of $2.9 Million in Common Stock

cool tech logo

Press Release – New York, NY – May 1, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Cooltech Holding Corp. (“Cooltech”), a consumer electronics, mobility and accessories distribution and marketing company, in connection with its sale of $2,859,000 of common stock to accredited investors. Cooltech sold 1,143,600 shares of common stock at a purchase price of $2.50 per share, pursuant to a private placement memorandum and related securities purchase agreement. Laidlaw & Company (UK) Ltd. acted as the placement agent for the private placement.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Marathon Patent Group, Inc. in $2.66 Million Registered Direct Offering

marathon patent group

Press Release – New York, NY – April 24, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Marathon Patent Group, Inc. (Nasdaq: Mara), an IP licensing and commercialization company, in a registered direct public offering of 3,800,000 registered shares of its common stock and 2,280,000 warrants at a price of $0.70 per share for gross proceeds of approximately $2,660,000.
continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for $2.1 Million Private Placement

protea biosciences

Press Release – New York, NY – April 17, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that between November 2016 and March 2017 it represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of Protea Biosciences Group, Inc. (OTCQB: PRGB), a molecular information company that has developed a technology which enables the direct analysis, mapping and display of biologically active molecules in living cells and tissue samples.

continue reading >>

Ronen Kantor

ronen kantor - Securities Law Firm | Sichenzia Ross Ference Kesner LLP

Managing Partner at DTKGC-SRFK*

Introduction

Ronen Kantor, Adv. is the founder of Kantor and Co. - Law offices and a managing partner of DTKGC . Mr. Kantor heads all the Corporate Finance Activities at DTKGC and is involved in most of the corporate transactions being managed by the firm. Mr. Kantor founded Kantor & co. Law Offices in 2000 with the goal of serving an increasing number of Israeli and foreign clients in various Corporate Finance activities both in Israel and internationally.

Mr. Kantor counsels public and private companies in securities matters in Israel, the US and the UK, and also in complex Merger and Acquisition transactions. Mr. Kantor's primary focus is corporate finance and securities laws, biotechnology and biopharmaceutical transactions, venture capital investments, private equity financings, mergers and acquisitions, general corporate law and other related activities.


*Ronen Kantor is a member of DTKGC-SRFK. This website is the website of the law firm Sichenzia Ross Ference Kesner LLP, a limited liability partnership doing business in New York and New Jersey. Services in Israel are provided through SRFK-DTKGC, a law firm organized under the laws of Israel that conducts business in Ramat Gan and Haifa in Israel. Sichenzia Ross Ference Kesner LLP and DTKGC-SRFK are each separate and independently owned firms. The Firms are parties to an affiliation agreement and operate under the global brands “Sichenzia Ross Ference Kesner LLP”, “SRFK LLP” and “DTKGC-SRFK”.

Professionals | Ronen Kantor | Sichenzia Ross Friedman Ference LLP

Education

University of Sheffield, England (LL.E. Honors, 1993)

Bar Admissions

Israeli Bar Association

Practice Areas

Corporate Law Group

Israeli Securities Law Group

Securities Law Group (U.S. and UK)

Israel practice group

Mergers and Acquisitions

Venture Capital & Investments

Private Equity Financings

Biotechnology & Licensing

International Transactions​

Contact Address

Office: Ramat Gan, Israel 5250606

Phone: +972-3-6133371

Fax: +972-3-6133372

Email: rkantor@dtkgc.com

Download vCard

Evan A. Berger

evan berger

Associate

Introduction

Evan A. Berger is an associate in the firm’s Corporate and Securities practice group. Mr. Berger represents public and privately-held companies in a wide range of corporate transactions.

Education

Mr. Berger received a J.D. from Fordham University School of Law where he was an associate editor for the Fordham Urban Law Journal and a member of the Brendan Moore Trial Advocacy Center. Mr. Berger received a B.A. from the University of Michigan.

evan berger

Education

J.D., Fordham University School of Law

B.A., University of Michigan

Bar Admissions

Mr. Berger is admitted to practice in New York and New Jersey

Practice Areas

Corporate law group

Securities law group

Contact Address

Office: New York

Phone: (212)-930-9700

Fax: (212)-930-9725

Email: eberger@srfkllp.com

Download vCard

Robert Volynsky

Associate

Introduction

Robert Volynsky is an associate in the firm’s Litigation Department. Mr. Volynsky engages in securities and general commercial litigation in both state and federal courts and before regulatory agencies, including the Securities and Exchange Commission and the Financial Industry Regulatory Authority. Prior to joining the firm, Mr. Volynsky interned as an Enforcement Intern in the Real Estate Finance Bureau at the New York State Attorney General’s office.

Education

Hofstra University School of Law, J. D. Honors Concentration in Business Law; Vice President, Dispute Resolution Society

University of California, Los Angeles, B.A.​

Bar Admissions

Robert is admitted to practice in California, New York, and New Jersey.

Practice Areas

Business Litigation & Arbitration

Contact Address

Office: New York

Phone: (212)-930-9700

Fax: (212)-930-9725

Email: rvolynsky@srfkllp.com

Download vCard

Sichenzia Ross Ference Kesner LLP Represents Tonix Pharmaceuticals Holding Corp. in $8 Million Shelf Take Down

tonix pharmaceuticals

Press Release – New York, NY – April 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Tonix Pharmaceuticals Holding Corp. (“Tonix”), a company that is developing innovative pharmaceutical products to address public health challenges, in connection with its underwritten public offering of 1,800,000 shares of its common stock at an offering price of $4.45 per share of common stock.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Investor in a Private Placement of up to $5,000,000 in Series B Preferred Stock of Digital Power Corporation

Press Release – New York, NY – March 29, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Philou Ventures, LLC (“Philou”) in connection with its entry into a Preferred Stock Purchase Agreement (the “Purchase Agreement”) with Digital Power Corporation, a California corporation (the “Company”), a solution-driven organization that designs, develops, manufactures and sells high-grade customized and flexible power system solutions for applications in the medical, military, telecom and industrial markets.  The Purchase Agreement was executed on March 9, 2017.

continue reading >>

Sichenzia Ross Ference Kesner LLP Partner Gregory Sichenzia Featured in Article Discussing Uptick in Coal and Gas IPOs

Press Release – New York, NY– March 28, 2017 – Sichenzia Ross Ference Kesner LLP founding partner Gregory Sichenzia was recently interviewed by Law360 about the return of coal and gas issuers to the initial public offering landscape after a long absence. Greg attributed the boost partly to a change in administration, as investors expect a friendlier regulatory environment under the Trump administration. The article, titled “Coal Cos. Are Forging A Return To The IPO Pipeline,” is available here.

Sichenzia Ross Ference Kesner LLP Advises Laidlaw & Co. (UK) Ltd. on U.S. Public Offering and NASDAQ Listing of Israeli Cannabinoid Research Company Therapix Biosciences, Ltd. (TRPX)

therapix biosciences logo

Press Release – March 27, 2017 – New York, NY – Sichenzia Ross Ference Kesner LLP (“SRFK”) announced today the successful completion of a U.S. underwritten public offering of American Depositary Shares by Therapix Biosciences Ltd. (“Therapix”) an Israeli public company.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents XTL Biopharmaceuticals Ltd., in a $2.8 Million Private Placement of ADSs.

xtlbio logo

Press Release – New York, NY – March 22, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented XTL Biopharmaceuticals Ltd.  (“XTLB. NASDAQ”), an Israeli biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of lupus and other autoimmune diseases, in a private placement offering with existing investors where XTLB issued 1,400,000 American Depository Shares (ADSs) at a purchase price of $2.00 per ADS.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in $3.85 Million Public Offering of Innovus Pharmaceuticals, Inc.

innovus pharma

Press Release – New York, NY – March 21, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw a unit of H.C. Wainwright as Exclusive Placement Agent in the public offering of common stock and Warrants of Innovus Pharmaceuticals, Inc. (“INNV.OTC).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $3.5 Million Public Offering

pareteum logo

Press Release – New York, NY – March 20, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSEMKT: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in an underwritten public offering of 2,333,334 shares of common stock at a public offering price of $1.50 per share together with the issuance of 1,166,667 five year warrants to purchase common stock with an exercise price of $1.87.

continue reading >>

Sichenzia Ross Ference Kesner LLP Partner Gregory Sichenzia Discusses Shareholder Comments that Impact Stock Price

Press Release – New York, NY– March 13, 2017 – Sichenzia Ross Ference Kesner LLP founding partner Gregory Sichenzia was recently interviewed by Business Insider about comments on Pandora stock by Liberty Media CEO Greg Maffei.  The article, titled “This media mogul has wreaked havoc on Pandora’s stock price for months — and he’s not slowing down,” discusses recent positive and negative comments by Mr. Maffei about Pandora. Greg addressed the legality of public statements that can impact stock price. 

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Cannabinoid Based Therapeutics Company in $12.3 Million Private Placement Led by Tuatara Capital Fund I, Ltd.

Press Release – New York, NY – March 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented a cannabinoid based life sciences corporation whose technology is designed to synthetically produce medically beneficial cannabinoids without utilizing the actual cannabis plant for the customized treatment of disease.

continue reading >>

Sichenzia Ross Ference Kesner LLP Founding Partner Gregory Sichenzia Featured in CNBC Story on Investing in Start-ups

Press Release – New York, NY – March 3, 2017 – Founding Partner Gregory Sichenzia was recently featured in a CNBC article authored by Kayleigh Kulp. The article entitled, “New Horizons: How to Invest in a Startup,” reviews the many things investors must know to effectively evaluate and invest in a start up.

continue reading >>

Mixiii BioMed 2017 Conference

Representatives of Sichenzia Ross Ference Kesner LLP and our affiliates, Doron, Tikotzky, Kantor, Gutman, Cederboum and Co., will be attending Biomed’s 16th National Life Science & Technology Conference, to be held at the David Intercontinental in Tel-Aviv, Israel on May 23rd – May 25th, 2017. Biomed has positioned itself throughout the years as the main annual meeting place for players of Israel’s healthcare industry with their colleagues from around the globe. It presents a unique and exuberating occasion for participating in discussions, panel presentations, product demonstrations and networking opportunities, all paving the way for new business collaborations.

May 23rd – May 25th, 2017
Tel-Aviv, Israel

David Intercontinental Hotel
Kaufmann St 12, Tel Aviv-Yafo, 61501, Israel

Learn More.

Oppenheimer’s 17th Annual Israeli Conference

Representatives of Sichenzia Ross Ference Kesner LLP and our affiliates, Doron, Tikotzky, Kantor, Gutman, Cederboum and Co., will be attending Oppenheimer’s 17th Annual Israel Conference, to be held at the David Intercontinental Hotel in Tel-Aviv on Sunday, May 21st 2017. Guests will include insurance companies, pension funds, provident funds, mutual funds, banks, venture capitals, and money managers. Based on previous years’ events, this conference is expected to attract approximately 500 participants, more than 40 Israeli companies, as well as considerable media coverage.

May 21st, 2017
Tel-Aviv, Israel

David Intercontinental Hotel
Kaufmann St 12, Tel Aviv-Yafo, 61501, Israel

Learn More

Pioneers 2017 Presented By Joseph Gunnar & Co., LLC

Sichenzia Ross Ference Kesner LLP is a sponsor of the Pioneers 2017 Conference presented by Joseph Gunnar & Co., LLC, to be held at the Mandarin Oriental in New York, NY on May 2nd, 2017. The conference will feature company presentations, one-on-one investor meetings and networking opportunities, with a focus on defense, tech and healthcare companies. Many members of Sichenzia Ross Ference Kesner LLP will be attending this event.

May 2nd, 2017
New York, NY

Mandarin Oriental
80 Columbus Circle,
New York, NY 10023

Learn More.

29th Annual ROTH Conference

Sichenzia Ross Ference Kesner LLP is a silver sponsor of the 29th Annual ROTH Conference, to be held at the Ritz Carlton in Dana Point, CA on March 12th – March 15th, 2017. The ROTH Conference, with close to 500 participating companies and over 4,000 attendees, will feature presentations from hundreds of public and private companies. The event will focus on healthcare, technology, internet & media, cleantech, industrial growth & solar, consumer, oil & gas, mining & minerals and business services.

March 12 – 15, 2017
Dana Point, CA

The Ritz Carlton
1 Ritz Carlton Dr
Dana Point, CA 9262

Learn More…

Sichenzia Ross Ference Kesner LLP Represents Aegis Capital Corp. and Laidlaw & Company (UK) Ltd. in $4.8 Million Public Offering

functionx logo

Press Release – New York, NY – February 28, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Aegis Capital Corp. and Laidlaw & Company (UK) Ltd. as joint book-running managers in the underwritten public offering of common stock of Function(x) Inc. (NASDAQ: FNCX).  Function(x) operates Wetpaint.com and Rant.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management as Warrant Agent in $2.3 Million Warrant Exchange and Exercise for AYTU BioScience, Inc.

aytu bioscience

Press Release – New York, NY – February 28, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC and Fordham Financial Management, Inc. as warrant solicitation agents in a $2.3 warrant exchange and exercise for Aytu Bioscience, Inc. (OTCQB “AYTU”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Medovex Corp. in $4.15 Million Private Placement and Debt Conversion

medovex corporation

Press Release – New York, NY – March 1, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented Medovex Corp. (NASDAQ:MDVX), a medical products manufacturer, in a private placement of units consisting of 3,071,634 shares of common stock and 1,535,817 warrants to purchase common stock at a fixed price of $1.04 per unit resulting in gross proceeds of $3,022,000.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents XTL Biopharmaceuticals Ltd. in $2.5 Million Registered Direct Offering

xtlbio logo

Press Release – New York, NY – February 27, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented XTL Biopharmaceuticals, Ltd. (NASDAQ: XTLB) (TASE: XTL.TA), an Israeli clinical-stage biopharmaceutical company developing treatments for autoimmune diseases, in a registered direct offering of 1,000,000 American Depository Shares (“ADSs”) at a price of $2.50 per share and unregistered warrants to purchase 1,000,000 ADSs at an exercise price of $4.10 per ADS for gross proceeds of $2,500,000. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. in $7 Million Public Offering

evoke pharma logo

Press Release – New York, NY – February 24, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as sole book-running manager in the underwritten public offering of equity securities of Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases. continue reading >>

Sichenzia Ross Ference Kesner LLP Founding Partner Gregory Sichenzia Discusses Delay of Fiduciary Rule on CNBC

Press Release – New York, NY– February 10, 2017 – Founding partner Gregory Sichenzia discussed the Trump administration’s potential rollback of the new fiduciary rule applicable to broker-dealers that was to go into effect in April 2018.  Greg noted that this new standard is likely to lead to substantial regulatory costs and may not result in better products or targeted advice.

 To view the video, click here.

Sichenzia Ross Ference Kesner LLP Partner Henry Nisser Interviewed by FinOps Report About Improper Handling of ADRs

Press Release – New York, NY – February 1, 2017 – Sichenzia Ross Ference Kesner LLP partner Henry Nisser was interviewed by the FinOps Report in its article titled “Pre-Release ADRs: More SEC Fines on the Way?” The article discusses ITG Inc.’s recent agreement to pay more than $24.4 million to settle charges that it violated federal securities laws when it prompted the issuance of American Depository Receipts (ADRs) without possessing the underlying foreign shares.  continue reading >>

Litigation Assistant

Sichenzia Ross Ference Kesner LLP is seeking a litigation assistant with 1-3 years of experience.

Job responsibilities include, but are not limited to:

  • Input billable hours of set name partners daily
  • Track and maintain retention chart of insurance cases and follow up with unpaid third-party invoices
  • Properly file and keep track of third-party document production of executed subpoenas and orders of production for cases
  • Manage deadlines on litigation calendar for department
  • Draft SEC and FINRA responses, bates stamp and properly file document productions
  • Prepare travel arrangements, manage personal calendars and screen phone calls for name partners
  • Assist in the preparation of mediations, depositions and hearings for litigation partners and associates
  • Experience in drafting table of contents and table of authorities required.
  • Experience in E-filing and using Pacer is preferred, but not required.

Please send resumes to mzavala@srfkllp.com

Senior Lawyer

Sichenzia Ross Ference Kesner LLP is seeking a senior lawyer or practice group with a portable business of at least $500,000 in the following disciplines: Mergers & Acquisitions, Commercial Real Estate Corporate/Transactional Tax, Executive Employment and Bankruptcy. Partnership potential. High pay outs. Great work environment and opportunity to cross-sell your practice with our existing core business of public company and investment banking clients.

Please contact mzavala@srfkllp.com

Sichenzia Ross Ference Kesner LLP Appoints Avital Even-Shoshan as Partner

Press Release – New York, NY– January 17, 2017 – The law firm of Sichenzia Ross Ference Kesner LLP today announced the promotion of Avital Even-Shoshan to partner.

“I am proud to congratulate Avital on this well-deserved promotion, which reflects her notable commitment to legal excellence and client service,” said founding partner Gregory Sichenzia. continue reading >>

Sichenzia Ross Ference Kesner LLP Appoints Morgan Weber as Counsel

New York, NY – January 17, 2017 – The law firm of Sichenzia Ross Ference Kesner LLP today announced the promotion of Morgan Weber to counsel.   

Morgan Weber, with over ten years of experience, is versed in complex litigation, in state and federal courts as well as before arbitration tribunals and regulatory agencies. She has substantial experience in litigation motion practice, discovery and trial preparation and appellate work in subjects relating to complex contracts, business litigation, intellectual property matters and real estate matters.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vycor Medical Inc. in an Internet Portal-based Private Placement

vycor medical inc.

Press Release – New York, NY – January 13, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Vycor Medical Inc. (OTCQB:VYCO) in a private placement with the Company’s existing accredited investor shareholders that was conducted  through an internet portal through which the Company provided potential investors with the offering  documents and accepted subscriptions.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and David Manno.

continue reading >>

Sichenzia Ross Ference Kesner LLP Founding Partner Marc J. Ross Discusses Employment Issues Surrounding Marijuana Use

Press Release – New York, NY – December 18, 2016 – Sichenzia Ross Ference Kesner LLP Founding Partner Marc J. Ross was recently quoted in The Atlantic, a CityLab article titled “Don’t Bet Your Job on Legal Pot.” The article notes that because marijuana remains illegal under federal law, employers are still able to fire employees for using marijuana, whether medical or recreational, even when such use is permissible under state law.

continue reading >>

Sichenzia Ross Ference Kesner LLP Adds Noted Intellectual Property Lawyer Scott H. Kaliko to Head the Firm’s New IP Group

Press Release — New York, NY — December 19, 2016 — Sichenzia Ross Ference Kesner LLP (“SRFK”), highly respected for their work in the securities and capital markets industries, continued its expansion and diversification for the firm’s practice today and announced the addition of noted intellectual property lawyer Scott H. Kaliko as Counsel to the firm to head the firm’s new intellectual property group. Kaliko joins SRFK from his own firm, Kaliko & Associates, LLC of thirteen years, prior to which he held roles at JP Morgan Chase & Co., and Fish & Neave, LLP (now Ropes & Gray, LLP).

continue reading >>

Sichenzia Ross Ference Kesner Partner Harvey Kesner Quoted on DTC Rule Changes

Press Release – New York, NY – December 15, 2016 – Sichenzia Ross Ference Kesner LLP partner Harvey Kesner was quoted by the FinOps Report in an update to its article titled “Transfer Agents, DTC Still Chilly On Issuer Freeze Policies.” The article discusses the Depository Trust Company’s (DTC) rule changes which specify four circumstances under which the DTC can “chill” or “lock” issuers out of its services. The SEC is responsible for approving any rule changes made by the DTC, the US national depository, and approved the new rules on December 6, 2016.
continue reading >>

Sichenzia Ross Ference Kesner LLP Attorneys Harvey Kesner, Michael Ference, Sameer Rastogi, and Mendy Piekarski Prevail in Removing a Shareholder Derivative Lawsuit to Federal Court

Press Release – New York, NY – December 14, 2016 – Sichenzia Ross Ference Kesner LLP today announced that attorneys Harvey Kesner, Michael Ference, Sameer Rastogi and Mendy Piekarski prevailed in removing a shareholder derivative lawsuit to federal court.

continue reading >>

Founding Partner Marc J. Ross, Esq. Quoted on Impact of Trump AG Pick on Legal Cannabis Industry

Press Release – New York, NY – December 9, 2016 – Sichenzia Ross Ference Kesner LLP founding partner Marc J. Ross, Esq. was recently quoted in a Boston Globe article titled “Trump AG pick could halt legal pot industry,” where he commented on the future of the Marijuana Industry.  The article discusses how Senator Jeff Sessions, Donald Trump’s nominee for attorney general, who many think has a long history of opposition to marijuana, could impact the marijuana industry across the United States.  In particular, Sessions could choose to remove the Cole Memorandum, effectively repealing the protections that exist for marijuana and marijuana-related businesses in the states where marijuana is legal.  
continue reading >>

Founding Partner Marc J. Ross Quoted in Forbes Article on Marijuana Entrepreneurs Who Want Donald Trump to See Them as Job Creators

Press Release – New York, NY – December 6 – Sichenzia Ross Ference Kesner LLP founding partner Marc J. Ross, Esq. was recently quoted in a Forbes article titled “Marijuana Industry Entrepreneurs Want Donald Trump To See Them As Job Creators.” The article discusses that even though Donald Trump’s selection of anti-drug hardliner Alabama Senator Jeff Sessions for his attorney general nominee has entrepreneurs in the legal marijuana industry worried, there is hope that the cannabis sector’s positive impact on job creation and tax revenues will influence Donald Trump to maintain the existing legal protections for marijuana businesses.  

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Oppenheimer & Co. in $3.6 Million PIPE for Ener-Core, Inc.

ener-core

Press Release – New York, NY – December 5, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Oppenheimer & Co., as Sole Placement Agent in private placement of $3.6 Million principal amount of convertible senior secured notes and warrants of Ener-Core, Inc.  (OTCQB. “ENCR”).

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $14.5 Million Registered Direct Offering.

vuzix view the future logo

Press Release – New York, NY – December 2, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 2 million registered shares of its common stock at a price of $7.25 per share for gross proceeds to Vuzix of $14,500,000. Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering. The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, Marcelle Balcombe and Counsel Jeff Cahlon.

Founding Partner Marc J. Ross Quoted on Inc.com on First Marijuana-Related Listing on the NYSE

Press Release – New York, NY – December 6, 2016 – Sichenzia Ross Ference Kesner LLP founding partner Marc J. Ross, Esq was quoted in an Inc.com article titled “NYSE Lists First Cannabis-Related Company.” The article discusses the IPO and NYSE listing of Innovative Industrial Properties, Inc., which will conduct business as an umbrella partnership real estate investment trust. The company focuses on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Oppenheimer & Co. and Feltl and Company in $13.5 Million PIPE for Midwest Energy Emissions Corp.

midwest energy

Press Release – New York, NY – November 18, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Oppenheimer & Co., as lead Placement Agent and Feltl and Company as Co-Placement Agent in a private placement offering of Common Stock ofMidwest Energy Emissions Corp. ME2C (OTCQB. “MEEC”). continue reading >>

Ten SRFK LLP Attorneys Named Super Lawyers & Rising Stars

Press Release — New York, NY — November 4, 2016  — Sichenzia Ross Ference Kesner LLP is pleased to announce that four partners have once again been named 2016 Super Lawyers. Additionally six other attorneys have been named 2016 Rising Stars.

Super Lawyers, a Thomson Reuters business, is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high degree of peer recognition and professional achievement. Each year, no more than five percent of the lawyers in New York  are selected by the research team at Super Lawyers to receive this honor.

The attorneys who have been selected for the 2016 honors are:  continue reading >>

Sichenzia Ross Ference Kesner LLP Selected to ‘Best Law Firms’ by US News and World Report

Press Release — New York, NY — November 3, 2016 – Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has been selected in the 7th Edition of Best Law Firms by US News & World Report for 2017 under the category of Corporate Law.  In addition, Founding Partner, Gregory Sichenzia has also been listed in Best Lawyers under the category of Corporate Law since 2016.

Sichenzia Ross Ference Kesner LLP Congratulates TapImmune Inc. on NASDAQ Uplisting

New York, NY – November 3, 2016 – Sichenzia Ross Ference Kesner LLP announced today that the Firm has represented TapImmune Inc. (NASDAQ: TPIV), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross  Ference Kesner LLP team was led by founding Partner Gregory Sichenzia and Associate Jay Yamamoto. The uplisting is effective for trading on November 8, 2016 and TapImmune’s common stock will trade under its existing stock symbol “TPIV.”

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar, Feltl and Company and Fordham Financial Management in $8.6 Million Public Offering of Aytu Bioscience, Inc.

aytu bioscience

Press Release – New York, NY – November 2, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co. and Feltl and Company as Joint Book -Running Managers and Fordham Financial Management, Inc. as Lead Manager in a firm commitment underwritten public offering of equity securities of Aytu BioScience, Inc.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Tonix Pharmaceuticals in $5.2 Million Public Offering

tonix pharmaceuticals

Press Release – New York, NY – November 1, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Tonix Pharmaceuticals Holding Corp. (NASDAQ “TNXP”), a developer of next-generation medicines for common disorders of the central nervous system, continue reading >>

Sichenzia Ross Ference Kesner LLP Represents ToughBuilt Industries, Inc. in $6.1 Million Private Offering

toughbuilt logo

Press Release – New York, NY – October 18, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented ToughBuilt Industries, Inc. (“ToughBuilt”) in a private placement of equity as well as debt securities.  ToughBuilt is a private company that markets and distributes various home improvement and construction product lines for both do-it-yourself and professional markets under the TOUGHBUILT® brand name within the global multi-billion dollar per year tool market industry.

continue reading >>

Sichenzia Ross Ference Kesner LLP Announces Change of Name

New York, New York October 17, 2016 — Sichenzia Ross Ference Kesner LLP, a leading securities and corporate law firm, is pleased to announce that Harvey Kesner has joined Gregory Sichenzia, Marc Ross and Michael Ference in renaming the firm “SRFK LLP.”  The newly renamed law firm represents the continuation of the firm’s 18 year commitment to excellence through serving the needs of public and private companies, their financiers and the broker-dealer and financial services community. The firm, previously named Sichenzia Ross Friedman Ference LLP and founded by Gregory Sichenzia, Marc Ross and Michael Ference 18 years ago, first welcomed Harvey Kesner as a partner in 2009.

continue reading >>

Sichenzia Ross Ference Kesner LLP Represents ABT Holdings, Inc. in $5 Million Private Offering of Senior Secured Convertible Debentures

abt logo

October 17, 2016 — New York, NY — Sichenzia Ross Ference Kesner LLP has represented ABT Holdings, Inc. (OTC.PK: ABOT), a diversified holding company engaged in investing, acquiring, developing, and growing various businesses, in a private offering of $5 Million of Senior Secured Convertible Debentures. continue reading >>

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for a $3 Million Private Placement

fte networks logo

Press Release – New York, NY – October 17, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as the exclusive placement agent in a private placement of equity securities of FTE Networks, Inc. (OTCQX: FTNW), continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Network 1 Securities in $7.7 Million IPO and NASDAQ listing of ShineCo, Inc.

shineco inc

Press Release – New York, NY – September 30, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it represented Network 1 Financial Securities, Inc. as underwriter in a $7.7 million best efforts Initial Public Offering of 1,713,190 shares of common stock of ShineCo, Inc. (Nasdaq TYHT) at a public offering price of $4.50 per share. Monarch Bay Securities participated as a selected dealer. Shineco is a producer and distributor of Chinese herbal medicines, organic agricultural produce and other health based plant products in China. The Sichenzia Ross Friedman Ference LLP team was led by Partners Marc Ross and Henry Nisser.

continue reading >>

Sichenzia Ross Friedman Ference LLP Represents BioPharmX Corporation in $930,000 Registered Direct Offering

biopharmx

Press Release – New York, NY – September 29, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it has represented BioPharmX Corporation (NYSE. MKT “ BPMX) in a Registered Direct public offering of 1,550,000 registered shares of its common stock at a price of $.60 per share and 1,240,000 unregistered warrants to purchase common stock at an exercise price of $.75 per share for gross proceeds to BPMX of $930,000. Rodman & Renshaw a Unit of H.C. Wainwright & Co., LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe and Counsel Jeff Cahlon.

continue reading >>

Partner Harvey Kesner Represents Towerstream Corporation in $4 Million Public Offering

towerstream

Press Release – New York, NY – September 26, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it has represented Towerstream Corporation (NASDAQ: TWER) in a firm commitment underwritten public offering of 2,962,963 shares of its common stock at a public offering price of $1.35 per share, for gross proceeds to Towerstream of $4,000,000. Laidlaw & Company (UK) Ltd. acted as the sole book running managing underwriter for the offering.

The Sichenzia Ross Friedman Ference LLP team was led by Partner Harvey Kesner, Avital Even-Shoshan and Evan Berger.

continue reading >>

Sichenzia Ross Friedman Ference LLP and its Israeli Affiliate DTKGC-SRFF Represent an Investment Group in Buy Out of ThermaSteel, Inc.

September 23, 2016 — New York, NY and Tel Aviv. Sichenzia Ross Friedman Ference LLP (“SRFF”) and Its Israeli Affiliate Doron Tikotzky Kantor Gutman Cederbaum-SRFF (“DTKGC-SRFF”) have represented an Israeli investment group led by Mr. Adi Ben-Senior in the acquisition of ThermaSteel, Inc. of Radford Virginia in a multi-million dollar transaction ThermaSteel has developed a patented bonding technology that bonds light gauge steel to EPS, creating composite structural wall panel system. www.thermsteelinc.com. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents General Cannabis Corp. in $2.6 million Private Offering of Senior Secured Notes and Warrants

general cannabis

September 22, 2016 — New York, NY –  Sichenzia Ross Friedman Ference LLP (“SRFF”)  has represented General Cannabis Corp. (OTCQB: CANN), a leading cannabis industry company, focused on being the all-in-one resource for quality service providers in the regulated cannabis industry, in a private offering of $2.6 million of Senior Secured Promissory Notes and Common Stock Purchase Warrants.

The Sichenzia Ross Friedman Ference LLP team was led by Partners Arthur Marcus and Gregory Sichenzia. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents SITO MOBILE, Ltd. in $11.5 Million Public Offering

sito - single touch interactive

Press Release – New York, NY – September 21, 2016 – Sichenzia Ross Friedman Ference LLP announced today that it has represented SITO Mobile, Ltd. (NASDAQ “SITO”) in a firm commitment underwritten public offering of 3,066,667 shares of its common stock, including exercise of the underwriter’s overallotment option, at a public offering price of $3.75 per share, for gross proceeds to SITO of $11,500,000. Cowen & Co. Inc. acted as the sole book running managing underwriter for the offering. The offering was led by several institutional investors.  The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, Counsel Jeff Cahlon and Associate S. Ashley Jaber.

continue reading >>

Sichenzia Ross Friedman Ference LLP is the Marquee Sponsor of the Aegis Capital Corp. 2016 Growth Conference in Las Vegas, Nevada

Press Release – New York, NY – September 16, 2016 – Sichenzia Ross Friedman Ference LLP is the Marquee Sponsor of the 2016 Aegis Growth Conference to be held at The Encore at Wynn Las Vegas September 20 through September 22, 2016.  A memorable and exciting conference is anticipated with numerous public companies presenting their businesses to a large audience of attendees.

On September 22, 2016, founding partner, Michael H. Ference will be moderating a panel focusing on Small Cap Financing. The panel will be comprised of experts in the field including: continue reading >>

Sichenzia Ross Friedman Ference LLP Attorneys Achieve Complete Dismissal of Lawsuit

Press Release – September 13, 2016 – New York, NY – Sichenzia Ross Friedman Ference attorneys Mendy Piekarski and Marc Ross achieve a complete dismissal of a lawsuit seeking unwarranted finder’s fees and commissions. Plaintiff sought fees for purportedly making introductions that resulted in certain corporate acquisitions and financings.

continue reading >>

1 2 3 9